Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
ANG.BOthis companyANG Lifesciences India Limited	₹36.93	-2.19×	0.46×	0.26×	141.24×	-50.6%	10.2%	-6.1%	-11.9%	-21.0%	-3.6%	14.0%	1.5×	106.97×	-0.71×	0.97×	0.0%	3	0.43	1	C-
BACPHAR.BOBacil Pharma Limited	₹16.82	43×	2.7×	0×	-270.7×	-93.7%	0.0%	0.0%	0.0%	6.3%	-1.0%	1.1%	0×	2.32×	0×	0.68×	0.0%	2	2.81	3	B-
CRSTCHM.BOCrestchem Limited	₹100.20	8.61×	2.36×	0.79×	5.99×	406.9%	17.8%	10.5%	9.2%	27.4%	22.5%	18.1%	0×	-0.11×	314×	0.9×	0.7%	4	—	3	B
DECCAN.BODeccan Health Care Ltd	₹12.09	6.78×	0.15×	0.21×	3.77×	191.3%	30.2%	4.4%	3.0%	2.3%	2.4%	-38.8%	0.04×	0.46×	9.89×	3.81×	0.0%	2	—	2	C+
GKB.BOGKB Ophthalmics Limited	₹58.91	21.69×	0.5×	0.18×	3.88×	-1189.8%	16.3%	3.6%	0.8%	2.3%	7.4%	-23.4%	0.22×	0.94×	2.01×	1.52×	0.0%	4	1.86	1	C-
GUJTERC.BOGujarat Terce Laboratories Limited	₹45.02	10.58×	2.39×	0.49×	5.8×	43.7%	29.2%	7.0%	4.6%	22.6%	16.2%	7.2%	0.13×	-0.42×	18.53×	1.32×	0.0%	2	3.69	2	C+
Peer median	—	10.58×	2.36×	0.21×	3.88×	43.7%	17.8%	4.4%	3.0%	6.3%	7.4%	1.1%	0.04×	0.46×	9.89×	1.32×	0.0%	2	2.81	2	—